L Letendre, J P Colgan, V L Hineman, H C Hoagland. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralAdolescentAdultAge FactorsDoxorubicin/administration & dosageDoxorubicin/therapeutic useDrug Therapy, CombinationFemaleHumansInjections, IntravenousLeukemia, Lymphoid/drug therapyMaleMiddle AgedPrednisone/administration & dosagePrednisone/therapeutic useVincristine/administration & dosageVincristine/therapeutic use
Substances: See more » VincristineDoxorubicinPrednisone
Year: 1982 PMID: 6953291
Source DB: PubMed Journal: Mayo Clin Proc ISSN: 0025-6196 Impact factor: 7.616